Early drug test halted: safety check on new injection
NCT ID NCT03764774
Summary
This early-stage study aimed to check the safety and side effects of a new drug called LY3463251 when given as an injection under the skin. It involved 118 healthy and overweight volunteers to see how their bodies handled single and multiple doses. The main goal was to gather basic safety information and understand how the drug moves through the body, not to treat a specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Inc
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.